ATOS (STOCKS)
Atossa Therapeutics, Inc. Common Stock
$5.200000
+0.260000 (+5.26%)
Prev close: $4.940000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Steven C. Quay
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $45.94M
- Employees
- 13
- P/E (TTM)
- -1.32
- P/B (TTM)
- 1.08
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Financial Statements
| Revenues | $0.00 |
| Operating Expenses | $37.14M |
| Research and Development | $21.19M |
| Other Operating Expenses | $15.96M |
| Operating Income/Loss | -$37.14M |
| Income/Loss From Continuing Operations After Tax | -$34.77M |
| Income/Loss From Continuing Operations Before Tax | -$34.77M |
| Income Tax Expense/Benefit | $0.00 |
| Net Income/Loss | -$34.77M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$34.77M |
| Net Income/Loss Available To Common Stockholders, Basic | -$34.77M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$4.04 |
| Diluted Earnings Per Share | -$4.04 |
| Basic Average Shares | 8,611,321 |
| Diluted Average Shares | 8,611,321 |
| Assets | $47.61M |
| Current Assets | $45.62M |
| Prepaid Expenses | $1.13M |
| Other Current Assets | $44.49M |
| Noncurrent Assets | $1.99M |
| Liabilities | $8.26M |
| Current Liabilities | $8.26M |
| Accounts Payable | $4.29M |
| Wages | $1.56M |
| Other Current Liabilities | $2.40M |
| Noncurrent Liabilities | $0.00 |
| Equity | $39.35M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $39.35M |
| Liabilities And Equity | $47.61M |
| Net Cash Flow From Operating Activities | -$29.76M |
| Net Cash Flow From Operating Activities, Continuing | -$29.76M |
| Net Cash Flow From Investing Activities | -$23.00K |
| Net Cash Flow From Investing Activities, Continuing | -$23.00K |
| Net Cash Flow From Financing Activities | $29.79M |
| Net Cash Flow From Financing Activities, Continuing | $29.79M |
| Net Cash Flow | $0.00 |
| Net Cash Flow, Continuing | $0.00 |
| Comprehensive Income/Loss | -$34.77M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$34.77M |
| Other Comprehensive Income/Loss | $0.00 |